Nearly two full years into the pandemic, COVID-19 still has the power to make or break a company’s bottom line. In BD’s case, even though the medtech giant spent the last year introducing new devices ...

Becton, Dickinson and Company BDX, popularly known as BD, along with Frazier Healthcare Partners, recently announced a definitive agreement for the former to acquire Parata Systems for $1.525 billion.

The BD P800™ Blood Collection System stands at the forefront of metabolic research, particularly in the context of obesity. Its unique ability to stabilize critical plasma markers has revolutionized ...

Editor’s note: Jim Shamp is Director of Public Relations at the N.C. Biotech Center. In this story, Shamp takes an in-depth look at BD’s growing presence in North Carolina. RESEARCH TRIANGLE PARK – BD ...

BD is pairing up with Labcorp to develop a new line of companion diagnostics for cancer treatments and therapies for other diseases, analyzing patients’ cells using flow cytometry technology to match ...

The January ribbon cutting at embecta‘s new global headquarters in Parsippany was the latest step for one of the world’s largest pure-play diabetes management companies. “It was a really important ...